ANLVSCMMB• 12 Months (Normalized)
ANL vs CMMB (Adlai Nortye Group Ltd. vs Chemomab Therapeutics Ltd.)
Showing Closing Date Range from Sep 29, 2025 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANL Performance $15.83
+%
Adlai Nortye Group Ltd.
Normalized Baseline0.00%
CMMB Performance $1.67
-36.98%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin ANL LEADS
+36.98 pts
ANL outperforming by 36.98 percentage points
ANLCMMB
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANL CMMB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | ANL Price | ANL Gain (%) | CMMB Price | CMMB Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $1.67 | -36.98% | - | |
| Sep 28, 2026 | $- | $1.64 | -38.11% | - | |
| Sep 25, 2026 | $- | $2.16 | -18.49% | - | |
| Sep 24, 2026 | $15.83 | +794.35% | $2.20 | -16.98% | +811.33% |
| Sep 23, 2026 | $15.75 | +789.83% | $2.28 | -13.96% | +803.79% |
| Sep 22, 2026 | $16.60 | +837.85% | $2.51 | -5.28% | +843.13% |
| Sep 21, 2026 | $15.57 | +779.66% | $2.48 | -6.42% | +786.08% |
| Sep 18, 2026 | $15.74 | +789.27% | $2.61 | -1.51% | +790.78% |
| Sep 17, 2026 | $15.28 | +763.28% | $2.80 | +5.66% | +757.62% |
| Sep 16, 2026 | $15.52 | +776.84% | $2.65 | +0.00% | +776.84% |
| Sep 15, 2026 | $15.00 | +747.46% | $2.47 | -6.79% | +754.25% |
| Sep 14, 2026 | $15.93 | +800.00% | $2.45 | -7.55% | +807.55% |
| Sep 11, 2026 | $15.21 | +759.32% | $2.58 | -2.64% | +761.96% |
| Sep 10, 2026 | $15.09 | +752.54% | $2.60 | -1.89% | +754.43% |
| Sep 09, 2026 | $14.70 | +730.23% | $2.69 | +1.51% | +728.72% |
Page 1 of 17